These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mycophenolate mofetil therapy for inflammatory eye disease. Thorne JE, Jabs DA, Qazi FA, Nguyen QD, Kempen JH, Dunn JP. Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096 [Abstract] [Full Text] [Related]
3. Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation. Galor A, Jabs DA, Leder HA, Kedhar SR, Dunn JP, Peters GB, Thorne JE. Ophthalmology; 2008 Oct; 115(10):1826-32. PubMed ID: 18579209 [Abstract] [Full Text] [Related]
4. Mycophenolate mofetil for the treatment of scleritis. Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR. Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873 [Abstract] [Full Text] [Related]
5. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis. Sobrin L, Christen W, Foster CS. Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998 [Abstract] [Full Text] [Related]
7. Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases. Gangaputra SS, Newcomb CW, Joffe MM, Dreger K, Begum H, Artornsombudh P, Pujari SS, Daniel E, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Kempen JH, SITE Cohort Research Group. Am J Ophthalmol; 2019 Dec; 208():68-75. PubMed ID: 31344346 [Abstract] [Full Text] [Related]
8. Mycophenolate mofetil for the treatment of uveitis. Teoh SC, Hogan AC, Dick AD, Lee RW. Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143 [Abstract] [Full Text] [Related]
9. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C. Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813 [Abstract] [Full Text] [Related]
10. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis. Kolomeyer AM, Ragam A, Shah K, Jachens AW, Tu Y, Chu DS. Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564 [Abstract] [Full Text] [Related]
14. Mycophenolate mofetil in the treatment of uveitis in children. Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M. Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M. Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494 [Abstract] [Full Text] [Related]
19. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation. Lau CH, Comer M, Lightman S. Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155 [Abstract] [Full Text] [Related]
20. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Rathinam SR, Babu M, Thundikandy R, Kanakath A, Nardone N, Esterberg E, Lee SM, Enanoria WT, Porco TC, Browne EN, Weinrib R, Acharya NR. Ophthalmology; 2014 Oct; 121(10):1863-70. PubMed ID: 24917273 [Abstract] [Full Text] [Related] Page: [Next] [New Search]